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Abstract
Background: A previous study showed that combination of zinc and vitamin A reduced sputum conversion time
in pulmonary tuberculosis (TB) patients.
Objective: We studied the efficacy of which single micronutrient contributed more to the sputum conversion
time.
Methods: In a double-blind randomized community trial, newly sputum smear positive pulmonary TB patients
were assigned randomly to receive zinc, vitamin A, zinc + vitamin A or placebo on top of TB treatment. Patients
were asked to deliver their sputum on weekly basis to measure positivity of the bacteria. Nutritional status, chest
x-ray, hemoglobin, C-reactive protein (CRP), retinol and zinc level were examined prior to, after 2 and 6 months
of treatment.
Results: Initially, 300 patients were enrolled, and 255 finished the treatment. Most patients were severely
malnourished (mean BMI 16.5 ± 2.2 Kg/m
2). Patients in the zinc + vitamin A group showed earlier sputum
conversion time (mean 1.9 weeks) compared with that in the other groups; however the difference was not
significant. Also, no benefit could be demonstrated of any of the used supplementations on clinical, nutritional,
chest x-ray, or laboratory findings.
Conclusions: This study among severely malnourished TB patients, did not confirm that single or combined
supplementation of zinc and vitamin A significantly reduced sputum conversion time or had other significant
benefit.
Background
The presence of micronutrient deficiencies among
tuberculosis (TB) patients has led to the question
whether micronutrient supplementation would give
additional benefits for the patients on top of the TB
treatment [1]. In a previous clinical trial of our group
found that combination of zinc and vitamin A supple-
mentation resulted in earlier sputum conversion than
placebo, which began as early as 2 weeks after the
administration of standard anti-TB treatment [2].
Vitamin A, as found as retinol in plasma, is one of
important micronutrient which has specific immune
function [3]. The presence of vitamin A deficiency in
sputum-positive pulmonary TB patients compared with
healthy subjects was confirmed [1,4]. and associated
with the future of pulmonary adult TB patients [5].
Zinc is a trace mineral, which is essential for the func-
tion of cells of the immune system, [6] and a mild defi-
ciency depresses the immune function in humans [7].
Zinc is also known as an essential mineral for normal
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[8].
As in other programs for the combat against TB, the
National Tuberculosis Program in Indonesia states that
the disappearance of acid-fast bacilli (AFB) from sputum
after treatment is basic in pulmonary TB patients’ man-
agement. The presence of AFB in sputum can be
assessed by direct visualization using the light micro-
scope, and can be confirmed by growth of Mycobacter-
ium tuberculosis in sputum culture. Conversion of
sputum smears to AFB-negative status is only used in
resource-limited countries [9] while in developed coun-
tries treatment success is measured by conversion to no
growth of Mycobacterium tuberculosis (MTB) in sputum
culture [10].
The effectiveness of anti-TB therapy is determined by
several factors, including the burden of mycobacteria,
underlying immune status, adherence to treatment, and
drug susceptibility. In the face of new threats to combat
tuberculosis, i.e. multidrug and extensively drug resis-
tance MTB, and also immunosuppressive diseases (HIV,
diabetes, malnutrition); the studies on micronutrients as
modulator of the immune system are important. It
would provide more evidence to the importance of sup-
plementation against tuberculosis. Following the pre-
vious finding in Jakarta, the present study aimed to
investigate the effect of single supplementation of zinc
or vitamin A or the combinations, on the sputum con-
v e r s i o nt i m ea n dt h eh e a l t hs t a t u so fn e w l yd i a g n o s e d
pulmonary TB patients. The study was done in Nusa
Tenggara Timur (NTT) province which was selected on
purpose, because of its relatively poorer than in Jakarta
with high prevalence of malnutrition and vulnerable of
food insecurity as reported by the ministry of health in
2005.
Methods
Study design, time and location
The design of the study was a double-blind, randomized
community trial. Prior to the study, randomization was
done using a computer program, in which a treatment
code was given to a subject. Every district had its ran-
dom allocation table consisted 60 patients plus addi-
tional randomization for another 50 patients, to
anticipate if one district had more patient than the
other.
Patients were given standard treatment for TB and
randomly divided into four supplementation groups:
zinc alone, vitamin A alone, zinc + vitamin A, and pla-
cebo. The supplementation was taken daily and the
patients were followed up until 6 months.
The primary outcome of the study was sputum con-
version time. Secondary outcomes were: nutritional sta-
tus (BMI, MUAC, % of body fat), abnormalities on chest
x-ray, and results of blood examinations (CRP, plasma
concentrations of zinc and vitamin A).
The study was conducted in Nusa Tenggara Timur
(NTT) Province, Indonesia, covering four districts in
Timor and Rote Island, namely Kupang City (the capital
of NTT), Kupang District, Timor Tengah Utara (TTU-
Northern Central Timor) district and Rote-Ndao dis-
trict, from January 2004 until December 2005.
Subjects and sample size
Subjects were newly diagnosed sputum smear-positive
(SS+) TB patients aged 15-55 years. Prior and during
the study, all pregnant or lactating females and subjects
who had underlying chronic or degenerative disease,
were excluded. All eligible patients were given informa-
tion regarding the study including problems that might
occur; and were asked to sign an informed consent for
their participations in the study. The sample size was
calculated based on the ability to determine a difference
with a =0 . 0 5a n d1 - b =0 . 8 0i ns p u t u mc o n v e r s i o n
time, nutritional status (BMI) and plasma concentrations
of retinol and zinc. As plasma retinol concentration was
the parameter requiring the largest sample size, it was
calculated that with a minimum sample size of 40 in
each group, a between-group difference of 0.12 μmol/L
in plasma retinol level could be detected based on the
previous study.
2 Accounting for a 40% drop-out rate,
each group in the intervention study comprised at least
56 subjects.
Micronutrient supplementation and anti-TB drugs
Supplements and placebo were prepared by Kimia Farma
Ltd, Indonesia, in the form of capsules. Each micronutri-
ent capsule contained 1500 retinol equivalents (5000 IU)
vitamin A (as retinyl acetate) and/or 15 mg zinc (as zinc
sulfate) in a lactose matrix. Dosage of zinc was determined
based on the recommended daily allowances for adult
Indonesians. Based on the previous study in Jakarta,
dosage of zinc was 15 mg in a form of zinc sulfate [2]. The
vitamin A given in the capsule was twice of the Indonesian
RDA, considering the possible deficiency and needs
to overcome inflammation process. As found in the pre-
vious study in Jakarta, 5000 IU of vitamin A in combina-
tion with zinc, was considered adequate and used in the
current study [2]. The placebo capsule consisted of lactose
alone. All capsules were similar in terms of shape, color
and size. Standard TB drugs were based on WHO guide-
lines, comprising 300 mg isoniazid, 450 mg rifampicin,
1500 mg pyrazinamide and 750 mg ethambutol daily for
2 months, followed by 600 mg isoniazid and 450 mg
rifampicin three times a week during the next 4 months.
To ensure adherence to the treatment, each patient had a
treatment-partner as recommended by WHO in the
DOTS strategy. The treatment-partner’s task was to
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blems occurred regarding TB treatment. They got money
when successfully maintained the treatment as it was
given by the donor of this study. Compliance of the
patients was measured monthly by the report of the treat-
ment partner, double cross-checked with the blister of the
TB drugs; as for the supplementation, we counted the left
over capsules that should be taken every month.
Data collection
All patients underwent physical examination, chest x-
ray, nutritional and food intake assessment as described
in other study [5], and blood analyses before the treat-
ment started, after the intensive phase, and at the end
of the treatment, except for sputum examination, which
was done weekly. HIV testing was not carried out since
t h ea r e ai ss t i l lk n o w na sal o wp r e v a l e n c ea r e af o rH I V
infection, as well as for HIV-TB co-infection [11].
Sputum conversion time
During the first 2 months of the study, the patients were
a s k e dt oc o m et ot h ec l i n i ce v e r yw e e kt od e l i v e rt h e i r
sputum for direct AFB smear examination. Three early
morning sputum specimens were taken from the patients
and examined by direct microscopy after Ziehl-Neelsen
staining in each Health Centre. The time was noted when
the first of three weeks’ consecutive sputum smears of
good quality was negative. In the case that either, not all
sputum samples were delivered, or the sputum was not of
adequate quality, the data were considered missing.
Chest x-ray examination
Chest X-rays were performed at diagnosis on all patients
and were evaluated by calculating the visible lesion area
in both lungs. In patients with cavities, the total area of
exposed cavity wall was calculated from the radius of
visible cavities (πr
2) as described before [2].
Nutritional status
Nutritional status was determined based on anthropo-
metric measurements and micronutrient concentrations
in the plasma. The anthropometrics measurements
were: body weight, height, body mass index, skinfold
thickness and percentage of body fat.
Body weight was assessed using an electronic platform
model weighing scale (770 alpha; SECA, Hamburg, Ger-
many) to the nearest 0.1 kg. Height was recorded to the
nearest 0.1 cm using a microtoise. BMI was calculated
as body weight divided by height squared (kg/m
2). Mid
upper arm circumference (MUAC) was measured using
a flexible measurement tape. Skinfold thickness was
measured at 4 sites: biceps, triceps, sub-scapular, and
supra-iliac regions, with a slim guide skinfold callipers
(Creative health product, Plymouth, Michigan, 48170),
recorded to the nearest 0.2 mm. The percentage of total
body fat was based on the skinfold data, and calculated
using the Durnin and Wormesley equations [12].
Blood examination
Blood samples were collected between 08.00 and
10.00 AM in the local health center. Approximately 15 mL
of fasting whole blood was withdrawn and separated into
4 vacutainers (Becton Dickinson, Rutherford, NJ) contain-
ing EDTA and heparin. Zinc and vitamin A concentration
were measured in plasma. C-reactive protein (CRP) was
measured to adjust the micronutrient deficiency in the
statistical analysis. Plasma was separated after centrifuga-
tion at 750 × g for 10 minutes at room temperature, and
then stored at minus 20°C until analyzed for CRP, retinol,
and zinc concentration at the SEAMEO-TROPMED
Laboratory, Jakarta. C-reactive protein (CRP) was mea-
sured using enzyme-linked immunosorbent assay (ELISA)
method with a normal value < 10 mg/L. Plasma retinol
concentration was measured by high performance liquid
chromatography (HPLC), values less than 0.70 μmol/L
were regarded as indicating deficiency, and values between
0.70 μmol/L and 1.4 μmol/L indicates marginal deficiency
[13]. Plasma zinc was analyzed using atomic absorption
spectrometry (AAS) with values >10.7 μmol/L regarded
as normal. Determination of hemoglobin, WBC, and ESR
were done on the same day at the provincial hospital
laboratory. Hemoglobin and WBC were analyzed using
automatic analyzer (ABX Micros 60, French). The cut-
off points for normal hemoglobin were >120 g/L and
>130 g/L for females and males respectively, and ESR was
assessed using Westengren technique with a normal value
< 20 mm/h. Serum albumin was measured using Spectro-
photometer (Microlab 300, Merck, Germany) with a
normal range 35-52 g/L.
Statistical analysis
A one-sample Kolmogorov-Smirnov test was used to
determine whether the variables were normally distribu-
ted. Data on the characteristics of the subjects at enroll-
ment for their age and gender distribution, nutritional
status, blood concentrations, and results of radiological
signs were summarized and used to assess the compar-
ability of the patients randomly assigned to the four
treatment groups. Different means between groups were
tested for significance using one-way ANOVA when
normally distributed, and Kruskal-Wallis test when not-
normally distributed. An extended analysis (ANCOVA)
was further applied for determining predictors of out-
come. Different proportions between groups were tested
using chi-squared test. Within group changes were
tested using paired student-t test for normally distribu-
ted data and the Wilcoxon signed-rank when for not-
normally distributed. A p value less than 0.05 were
considered significant. An intention to treat analysis was
applied. Statistical analyses were performed using com-
puter software SPSS for Windows PC version 14.0
(SPSS Inc, Chicago, IL, USA) [14].
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This study adhered to the Council for International
Organizations of Medical Sciences guidelines (CIOMS,
1991). Data were collected after subjects agreed to parti-
cipate in the study and gave written informed consent
voluntarily. The research proposal was approved by the
Ethics Committee of the Faculty of Medicine, University
of Indonesia.
Results
A total of 300 patients were enrolled into the study and
randomly grouped into 4 categories of intervention, i.e.
supplementation of zinc (n = 76), vitamin A (n = 72),
combined zinc + vitamin A (n = 66) and placebo (n =
86). After two months 274 patients were still in the
study and analyzed, while 255 patients completed the
study after 6 months and were analyzed. (Figure 1). Of
all subjects, we received report from the treatment-part-
ners that 22 patients (of total 255 patients who
completed TB treatment) were not compliance to the
study procedure.
Patients’ mean age was 31.5 years and 63% of them
were men (Table 1). Sputum positivity grade 3 was most
prevalent. The prevalence of cavities on chest X-ray was
almost 40% for all groups. These findings suggested that
the patients had severe TB. There was no difference of
baseline characteristics among the 4 groups of patients
except for the proportion of patients with cavities
(Table 1).
In total 237 patients delivered all required sputum sam-
ples and of good quality and the rest was considered as
missing data. As shown in table 1, mean sputum conver-
sion time of the zinc + vitamin A intervention group was
the shortest, and that of the zinc intervention group the
longest. The zinc + vitamin A (n = 50) and vitamin A
groups (n = 56) showed less weeks to reach 85% of spu-
tum conversion, followed by the placebo group (n = 62).
The zinc supplementation group (n = 68) showed the
Figure 1 Trial profile. Including reasons for patients’ drop out during the study.
Pakasi et al. Nutrition Journal 2010, 9:41
http://www.nutritionj.com/content/9/1/41
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ever, no significant difference of the sputum conversion
time was observed between groups (ANCOVA, p > 0.05).
Factors included in the analysis were AFB level, compli-
ance, and the differences of zinc and retinol level from
the baseline. After one week, sputum was smear negative
in 58.5% of patients from the zinc + vitamin A group, in
45.6% of patients in the vitamin A and placebo groups,
whereas the zinc group showed the lowest percentage
(35.3%). The zinc + vitamin A (n = 50) and vitamin A
groups (n = 56) showed less weeks to reach 85% of spu-
tum conversion, followed by the placebo group (n = 62).
The zinc supplementation group (n = 68) showed the
longest time to reach 85% of sputum conversion. After
two months no significant differences were found
between the groups (Figure 2). Taking into account the
WHO success rate target of 85% conversion to negative,
we observed that patients in the zinc + vitamin A supple-
mentation group reached the target within 4 weeks, simi-
lar to the vitamin A group, followed by placebo group
(5 weeks), and zinc group (6.6 weeks).
Mean BMI for the four groups varied from 16.4 - 16.6
and was 16.5 for all 300 patients, indicating severe mal-
nutrition (Table 2). Fifty percent of the patients had
BMI lower than 16.5 Kg/m
2 when enrolled in the study;
the rest was moderate malnutrition (33%) and normal
nutritional status (17%). The mean value of MUAC and
percentage body fat were extremely low.
After 2 months of treatment, there were significant
improvements of micronutrient status within groups
compared with the initial levels, particularly in patients
given combined vitamin A and zinc supplementation or
placebo (Table 3). The proportion of cavities on chest
x-ray was significantly different between the four groups
but not after 6 months of treatment (Table 1). The
changes of the proportions between groups however,
were not significant. At the end of treatment, significant
changes from the baseline were observed for all variables
except for zinc concentration in the group receiving vita-
min A and the group receiving zinc + vitamin A, but no
difference between groups was observed (Table 1).
Discussion
In this double-blind randomized community trial, sup-
plementation with zinc and vitamin A, either alone or
combined, failed to show superiority over placebo. This
was unexpected, as we could not confirm the results of
the previous study in Jakarta, in which vitamin A and
zinc supplementation was beneficial in terms of sputum
conversion time [2]. Results similar to ours with regard
Table 1 Changes on sputum smear AFB and radiograph after 2 and 6 months
Variables Groups
Zinc Vitamin A Vitamin A + Zinc Placebo
Age (year), mean ± SD 30.9 ± 11.8 33.1 ± 11.5 30.1 ± 12 31.4 ± 10.4
Gender (n,%):
Male 51 (67.1) 46 (63.9) 42 (63.6) 50 (58.1)
Female 25 (32.9) 26 (36.1) 24 (36.4) 36 (41.9)
Sputum smear grade (n,%):
+ 1 18 (23.7) 22 (30.6) 25 (37.9) 24 (27.9)
+ 2 24 (31.6) 19 (26.4) 18 (27.3) 30 (34.9)
+ 3 34 (44.7) 31 (43) 23 (34.8) 32 (37.2)
Sputum conversion time (wk), mean ±SD 3.02 ± 2.2 2.1 ± 1.6 1.94 ± 1.4 2.5 ± 1.7
Duration to achieve WHO target(wk), mean † 6.6 4.0 4.0 5.0
Number of cavity (n,%)
0 month* 18 (25.7) 35 (51.5) 25 (38.5) 36 (41.9)
2 month* 5 (7.5) 17 (27) 8 (14.8) 13 (17.1)
6 month 5 (8.1) 3 (5.3) 2 (3.6) 3 (4.2)
Cavity surface area (cm
2), median (IQR)
0 month 10.2 (4.9-17.4) 12.0 (6.2-22.1) 12.9 (4.8-15.9) 10.2 (4.9-21.6)
2 month 6.2 (2.5-21)‡ 5.5 (2.5-13.7)‡ 5.9 (2-16.2)‡ 4 (3.1-10)‡
6 month 0 (0 - 0)‡ 0( 0-0 ) ‡ 0 (0- 0)‡ 0( 0-0 ) ‡
Total lesion area (cm
2), median (IQR)
0 month 120 (71-179.8) 139 (44-216) 143 (73-198) 129 (62-209)
2 month 40.5 (12-100)‡ 35 (0-80)‡ 37 (9-94.5)‡ 32.5 (4.5-77.5)‡
6 month 0 (0-42.4)‡ 0 (0-25.8)‡ 0 (0-21)‡ 0 (0-25.8)‡
SD = standard deviation, IQR = interquartile range; *significant difference of proportion between groups (chi-squared, p < 0.05); significant changes from baseline
p < 0.001‡; number of good quality sputum analyzed for zinc, vitamin A, zn + vitamin A and placebo groups were: 62, 57, 50, and 68 respectively (total 237).
†WHO target: 85% subjects in a group converted into SS negative.
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Page 5 of 10Figure 2 Cumulative percentage of the sputum conversion time. The zinc + vitamin A (n = 50) and vitamin A groups (n = 56) showed less
weeks to reach 85% of sputum conversion, followed by the placebo group (n = 62).
Table 2 Changes of anthropometric measurements prior to, at two and six months of treatment
Variables Groups
Zinc Vitamin A Zinc+ Vit A Placebo
BMI (kg/m
2), mean ± SD
0 month 16.5 ± 2.2 16.5 ± 2.2 16.6 ± 2.1 16.4 ± 2.5
2 month 17.7 ± 2.3‡ 17.8 ± 2.2‡ 17.7 ± 2.0‡ 17.5 ± 2.4‡
6 month 18.5 ± 2.22‡ 18.1 ± 2.42‡ 18.3 ± 2.02‡ 18.4 ± 2.62‡
Increasing BMI from the baseline
(kg/m
2), mean ± SD
0 to 6 month 1.9 ± 1.3 1.7 ± 1.6 1.9 ± 1.5 2.0 ± 1.4
MUAC (cm), median (IQR)
0 month 21.1 (19.8-23.1) 21 (20-23) 21.3(20-23.6) 21.8(19-23.6)
2 month 23 (21-25)‡ 22 (20.1-24.7)‡ 23 (21-24)‡ 23 (20.8-24.5)‡
6 month 24 (22.5-25.1)‡ 23.0 (21.8-25.0)‡ 24.0 (22.0-25.3)‡ 24 (22.5-26)‡
Body fat (%),mean ± SD
0 month 11 ± 4.5 11 ± 6.2 10.8 ± 4.7 11.9 ± 5.9
2 month 12.9 ± 5.0‡ 13.3 ± 5.9‡ 12.9 ± 5.1‡ 14.2 ± 6.1‡
6 month 14.5 ± 5.82‡ 14.2 ± 6.42‡ 14.2 ± 6.42‡ 16.0 ± 6.32‡
SD = standard deviation, IQR = interquartile range, significant changes from baseline, paired student-T ‡p < 0.001.
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Tanzania [15], where such supplementation did not lead
to a reduction of sputum conversion time compared to
supplementation with a multi-micronutrient or placebo
either. Also, zinc supplementation did not improve
immune response among TB patients infected with HIV
in a study in Singapore [16]. The authors further con-
cluded that in the absence of zinc deficiency, additional
zinc supplementation was not beneficial. And to the
best of our knowledge, the data on the effect of vitamin
A supplementation in TB were inconclusive [17-19].
How can we explain the discrepancy between the
results of the Jakarta study and the current results?
The first explanation might be found in retinol concen-
trations and inflammatory response at baseline. In the
Jakarta study, higher mean retinol concentrations
(0.8 μmol/L and 0.9 μmol/L for the supplemented and
placebo groups, respectively) were found than in the
current study (0.7 μmol/L for all groups) [2]. The mean
baseline CRP concentrations in the Jakarta study
(53 mg/L for the micronutrient group and 44.1 for the
placebo group) were almost twice as high as in the cur-
rent study (mean CRP for all groups = 28.4 mg/L).
Higher CRP concentrations reflect a stronger inflamma-
tory response, which is known to lower the plasma reti-
nol concentrations [20]. Thus, the patients in the Jakarta
study may have had a lesser degree of vitamin A defi-
ciency, inflammation leading to the low plasma retinol
levels. This might imply that higher dosages of vitamin
A supplementation would have been needed for the TB
patients of the current study to reach retinol concentra-
tions necessary for a clinical effect. This was also proven
by the concentration of retinol at 2 and 6 months of
intervention, which could not elevate the retinol level in
the plasma. This is in line with the study in Malawi
which concluded that supplementations at the level of
recommended daily allowance (RDA) did not meet their
main outcomes [21]. In contrast with this, the study in
Table 3 Changes in blood parameters prior to, at two and six months of treatment
Variables Groups
Zinc Vitamin A Zinc+ Vit A Placebo
Plasma CRP (mg/L), median (IQR)
0 month 25.7 (13.7-38.8) 27.9 (11.5-42.1) 29.1 (12.6-43.0) 30.9 (13.3-47.4)
2 month 4.6 (1.4-13.8) ‡ 4 (1-14.3)‡ 4.2 (1.3-15.5) ‡ 6.4 (1.5-14.6) ‡
6 month 1.3 (0.5-2.7)‡ 1.5(0.6-3.3)‡ 1.1 (0.5-4.4) ‡ 1.7 (0.9-40)‡
Serum albumin (g/dL), mean ± SD
0 month 3.8 ± 0.84 4.0 ± 0.75 4.0 ±0.96 3.8 ± 0.83
2 month 4.5 ± 0.68‡ 4.3 ± 0.88† 4.4 ± 0.74 4.4 ± 0.78‡
6 month 4.6 ± 0.52‡ 4.6 ± 0.72‡ 4.7 ± 0.62‡ 4.6 ± 0.52‡
Leukocytes(cells/mm
3),median (IQR)
0 month 9300 (7575-13000) 9750 (7775-11575) 10200 (7475-12250) 9750 (7000-2225)
2 month 6700 (5400-8100)‡ 6600 (5600-8050)‡ 7500 (5500-8875)‡ 7300 (5900-9100)‡
6 month 6000 (5100-7000)‡ 6900 (5275-8100)‡ 6800 (5850-7800)‡ 6800 (5800-8100)‡
ESR (mm),median (IQR)
0 month 73.0 (48.0-99.5) 59.5 (40.0-88.5) 62.0 (36.0-92.0) 75.0 (42.0-109.0)
2 month 28 (16-40)‡ 31 (18-40)‡ 30 (17.3-38.8)‡ 28 (16-45)‡
6 month 11 (4-28)‡ 14 (8-28.8)‡ 12 (6-28)‡ 11 (8-28)‡
Hemoglobin(g/dL), mean ± SD
0 month 11.2 ± 2.7 11.6 ± 2.4 11.6 ± 2.5 11.0 ± 2.5
2 month 12.5 ± 2.78‡ 12.6 ± 2.55‡ 13.18 ± 2.48‡ 12.12 ± 2.43‡
6 month 12.8 ± 2.3‡ 13.0 ± 2.2‡ 13.3 ± 2.2‡ 12.8 ± 2.3‡
Plasma zinc(μmol/L), mean ± SD
0 month 11.6 ± 2.2 11.9 ± 3 12.1 ± 3.0 11.8 ± 2.4
2 month 11.7 ± 2.43† 11.6 ± 1.83‡ 12.5 ± 2.33‡ 11.7 ± 2.33‡
6 month 13.1 ± 1.92† 12.5 ± 2.1† 12.8 ± 2.9† 12.6 ± 1.7 3‡
Plasma retinol(μmol/L), median (IQR)
0 month 0.7(0.5-1.0) 0.7(0.5-1.5) 0.7(0.4-1.1) 0.7 (0.5-1)
2 month 1.2 (1-1.6)
a‡ 1.5(1-2)
ab‡ 1.3 (1-1.9)‡ 1.2 (0.9-1.6)
b‡
6 month 1.4 (1.1-1.9)† 1.6 (1.2-2.0)‡ 1.6 (1.2-1.9) 1.4 (1.0-1.8)‡
SD = standard deviation, IQR = interquartile range, *significant difference of proportion between groups (chi-squared, p < 0.05), significant changes from baseline
p < 0.05† and p < 0.001‡,
ab significant changes between group (One-way ANOVA, p < 0.05).
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tions four to ten times higher than the RDA, reduced
TB recurrences among the HIV-positive adults with TB,
and increased T-cell counts of the HIV-negative patients
[22]. With regard to zinc on the other hand, the level at
baseline were already slightly above the deficiency cut
off (10.7 μmol/L). This may explain the lack of efficacy
observed for zinc [2].
T h es e c o n de x p l a n a t i o nm a yb ec o n n e c t e dt ot h ed i f -
ferences in the chest radiographs and the grading of
sputum AFB positivity, an important predictor of spu-
tum conversion [23]. The number of patients with cav-
ities in our study was similar (38%) to that in the
Jakarta study (37.5% of total patients in both group).
More important however, is that in the present study,
the proportion of patients with cavities among the four
groups differed significantly at baseline (Table 1), with
the highest proportion of cavities (51.5%) being present
in the patients of the vitamin A supplementation group.
This imbalance may have obscured the effect of vitamin
A supplementation but would not explain the lack of
effect in the zinc + vitamin A group. Findings of a Span-
ish study showed the association between the presence
of cavity and the conversion time in the presence of
HIV co-infection. It was concluded that cavity pro-
longed the conversion time, and the presence of HIV
lowered the prevalence of cavity production in the lungs
as captured in the chest x-ray. Thus, the absence (prob-
ably very small proportion) of HIV co-infection in the
current study led to cavity formation in the lung and at
the end prolonged the conversion time [24].
The severity of TB in our patients is witnessed by the
fact that 40% had sputum AFB positivity grade 3 prior
to treatment whereas in the Jakarta study 68% had
grade 1 (for both supplemented and placebo groups)
and this can be expected to lead to longer sputum con-
version time [23]. It may be that the supplementation
effect does not become clear in such severe cases.
The third explanation for the difference between the
current study and the previous study in Jakarta is related
to the sample size. In Jakarta, the sample size was esti-
mated “on the ability to determine a difference of retinol
cosentration in plasma, with an alpha = 0.05 and 1-beta =
0.95 with use of a one-tailed test for concentrations of
hemoglobin in blood, and of retinol and zinc in plasma.”
[2] The findings in the Jakarta trial, of an effect of zinc
+vitamin A supplementation on the sputum conversion
time was unexpected as no sample size was estimated for
this specific outcome. In the present study, designed for
confirmation of the previous results, the effect on sputum
conversion time was not found. Thus, the probability is
real that the finding in the first study was not valid, due to
underpowerment of the study to measure a difference in
sputum conversion time.
Another explanation may be related to the observation
that the patients in the current study were more mal-
nourished than the patients in the Jakarta study. Mean
BMI of our cohort was 16.5 Kg/m
2 as compared to 18.5
Kg/m
2 in the Jakarta study [2]. There was no available
population based study on adult malnutrition, however
a recent study found 33% of under nutrition occurred
among neighbors of the TB patients [25]. Such a low
BMI may reflect two processes. One would be protein
energy malnutrition (which severely affects host defense)
and the other wasting due to the catabolism induced by
the acute phase response [26]. As found in our subjects,
the BMI increased along with reducing of inflammation.
When the patients got healed, as shown in the total
lesion area of lung, they gained more weight and also of
other micronutrients, such as iron, zinc and vitamin A.
(table 1 and 3) This might explain how the hemoglobin
increased, although it was still in the borderline to be
considered normal.
Neither of low intake or wasting is directly affected by
supplementation of micronutrients and hence it may
n o tb er e m a r k a b l et h a tw ef a i l e dt os h o wa ne f f e c ti n
this study. Beside macronutrient deficiencies, there was
also the possibility that additional micronutrients defi-
ciency were present in the study population, which
could not be corrected with zinc and vitamin A.
For example, vitamin D has been implicated in
defense against TB, but vitamin D deficiency is a world-
wide problem. Furthermore there might be a link
between vitamin D deficiency with ethnicity. In the
Jakarta study, the patients were mainly from Java, Sunda
and Sumatra, with a minority of others, the current
study consists mainly of patients indigenous to Timor
and Rote islands [27]. We found in the same study areas
that ethnicity was associated with the development of
TB and severity of TB [28,29]. In line with this, a recent
study showed that vitamin D receptor genetic poly-
morphisms were associated with the time to sputum
culture conversion [30]. Also it was shown that vitamin
D receptor genotype independently predicted the spu-
tum smear conversion time while on anti-TB therapy
[31]. One might speculate that ethnic background also
plays a role in the response to supplementation with
micronutrients.
We conclude that the patient groups studied here,
were suffering from severe tuberculosis with cavities in
at least one third of the patients, and high sputum posi-
tivity grade. The patients were vitamin A deficiency
whereas zinc was at borderline but sufficient to support
the immune system and perhaps more important, also
severely malnourished. It was also important to notice
that the supplementation could not elevate the level of
retinol and zinc plasma higher than its borderline.
Against this background we were not able to replicate
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eficial effect of vitamin A and zinc in tuberculosis. This
means that the previous findings in Jakarta cannot be
generalized. For further studies, a larger sample size will
be required, and higher dosages of the zinc and vitamin
A supplementations should be considered. Also, in
patients with very low BMI, the effect of protein supple-
mentations needs further study.
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